How NSTEMIs Are Classified
NSTEMIs are classified primarily by risk stratification (low, intermediate, or high risk for death or nonfatal MI) and by pathophysiologic type (Type 1 through Type 5 MI), with Type 1 representing acute coronary atherothrombosis and being the most common form (65-90% of cases). 1, 2, 3
Primary Classification Systems
Risk-Based Classification
The most clinically actionable classification stratifies NSTEMI patients into three risk categories based on short-term risk of death or nonfatal MI 1, 2:
High-Risk Features:
- Elevated cardiac troponin (particularly marked elevation)
- New or presumed new ST-segment depression ≥0.5 mm
- Prolonged ongoing rest pain (>20 minutes)
- Pulmonary edema likely due to ischemia
- New or worsening mitral regurgitation
- Hemodynamic instability
- Sustained ventricular tachycardia
- Age >75 years
- Depressed left ventricular ejection fraction (<0.40)
Intermediate-Risk Features:
- Prior MI, peripheral or cerebrovascular disease, or prior CABG
- Prolonged rest angina (>20 minutes), now resolved
- Age >70 years
- T-wave changes or pathological Q waves
- Slightly elevated cardiac troponin
Low-Risk Features:
- New-onset or progressive angina within past 2 weeks to 2 months
- Normal or unchanged ECG
- Normal cardiac biomarkers
This risk stratification directly determines management strategy: high-risk patients require early invasive strategy (angiography within 12-48 hours), intermediate-risk patients warrant individualized approach, and low-risk patients can be managed with early conservative strategy 1, 2, 4.
Pathophysiologic Classification (Universal Definition)
NSTEMIs are further classified by underlying mechanism 5, 6, 3:
Type 1 MI (65-90% of NSTEMIs): Acute coronary atherothrombosis from plaque rupture or erosion with partial or complete vessel thrombosis. This is the classic "acute coronary syndrome" requiring antiplatelet therapy and consideration for revascularization 3.
Type 2 MI: Myocardial oxygen supply-demand mismatch unrelated to acute coronary atherothrombosis (e.g., severe anemia, hypotension, tachyarrhythmia, coronary vasospasm). These patients have multiple comorbidities and require treatment of the underlying precipitant rather than routine invasive management 3, 7.
Type 3 MI: Cardiac death with symptoms of myocardial ischemia but death occurring before biomarkers obtained 6.
Type 4 and 5 MI: Procedure-related (PCI-related and CABG-related, respectively) 6.
Important Clinical Distinctions
NSTEMI vs. Unstable Angina
NSTEMI is distinguished from unstable angina solely by the presence of elevated cardiac biomarkers (troponin) indicating myocardial necrosis. The clinical presentations are otherwise identical, and both fall under the umbrella term "NSTE-ACS" (non-ST-elevation acute coronary syndrome) 5, 2, 8.
Occluded vs. Non-Occluded Culprit Artery
Approximately 33% of NSTEMIs have complete occlusion of the culprit artery despite lacking ST-elevation on ECG 9, 10. These patients have similar myocardial damage to STEMI patients and worse outcomes than NSTEMIs without occlusion. Emerging AI-powered ECG models show promise in identifying this high-risk subset 11.
Practical Application
The risk-based classification system takes precedence in clinical decision-making because it directly determines timing of angiography and intensity of medical therapy 2, 4. The pathophysiologic classification (Type 1 vs. Type 2) is critical for determining whether invasive management is appropriate—Type 1 benefits from revascularization while Type 2 requires addressing the underlying precipitant 3, 7.
Risk scores like TIMI (Thrombolysis In Myocardial Infarction) and GRACE (Global Registry of Acute Coronary Events) provide validated tools for quantifying risk and guiding management decisions 1, 12.